chr4-56966709-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032313.4(NOA1):c.1675G>A(p.Val559Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000446 in 1,612,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032313.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NOA1 | NM_032313.4 | c.1675G>A | p.Val559Met | missense_variant | 5/7 | ENST00000264230.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NOA1 | ENST00000264230.5 | c.1675G>A | p.Val559Met | missense_variant | 5/7 | 1 | NM_032313.4 | P1 | |
REST | ENST00000640168.2 | c.*28C>T | 3_prime_UTR_variant | 3/3 | 1 | ||||
REST | ENST00000640343.2 | c.*28C>T | 3_prime_UTR_variant | 4/4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 151956Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251198Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135782
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1460918Hom.: 0 Cov.: 30 AF XY: 0.0000550 AC XY: 40AN XY: 726866
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | The c.1675G>A (p.V559M) alteration is located in exon 5 (coding exon 5) of the NOA1 gene. This alteration results from a G to A substitution at nucleotide position 1675, causing the valine (V) at amino acid position 559 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at